
Chiasma, Inc. CHMA
Chiasma, Inc. DIO Ratio 2011-2026 | CHMA
Annual DIO Ratio Chiasma, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 65.6 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 65.6 K | 65.6 K | 65.6 K |
DIO Ratio of other stocks in the Biotechnology industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Midatech Pharma plc
MTP
|
40.6 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
512 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
4.89 | $ 0.88 | -2.05 % | $ 6.47 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
295 | $ 22.46 | 0.72 % | $ 3.72 B | ||
|
BioDelivery Sciences International
BDSI
|
321 | - | -4.8 % | $ 255 M | ||
|
CASI Pharmaceuticals
CASI
|
47.4 | - | - | $ 35.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
275 | - | - | - | ||
|
ChromaDex Corporation
CDXC
|
69.7 | - | -0.88 % | $ 598 M | ||
|
Aeterna Zentaris
AEZS
|
55.6 | - | 5.93 % | $ 314 M | ||
|
Aquestive Therapeutics
AQST
|
120 | $ 4.08 | -0.61 % | $ 436 M | ||
|
Arcutis Biotherapeutics
ARQT
|
185 | $ 23.06 | -1.54 % | $ 2.93 B | ||
|
Heron Therapeutics
HRTX
|
644 | $ 1.22 | 2.1 % | $ 203 M | ||
|
ImmuCell Corporation
ICCC
|
185 | $ 8.34 | 1.07 % | $ 75.3 M | ||
|
Autolus Therapeutics plc
AUTL
|
70.7 | $ 1.49 | 4.58 % | $ 397 M | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
BeiGene, Ltd.
BGNE
|
304 | - | 0.49 % | $ 251 B | ||
|
bluebird bio
BLUE
|
125 | - | - | $ 546 M |